Newly Discovered Lung Immune Cells Could Transform Future Flu Vaccine Design
The cells produce galectin-1 and helped an experimental nasal flu vaccine trigger a stronger lung immune response in mice, researchers said.
4 Articles
4 Articles
Researchers from the Rochester University of Medicine in the United States have revealed that some kind of immune cell known as the lone cells can remain in the lungs for months after the influenza, contribute to the support of TEM cells and strengthen the body ' s ability to respond to the virus again, in a discovery that could help develop more effective influenza vaccines.
Newly discovered lung immune cells could transform future flu vaccine design
Influenza continues to cause major illness each year in the United States, leading to more than 35,000 deaths annually. Children, older adults, pregnant individuals, people with weakened immune systems, and those with chronic conditions such as heart disease, metabolic disorders, and cancer are especially vulnerable.
Key Immune Cells Identified That Could Strengthen Flu Vaccines
New research identifies long-lived lung immune cells that support protective T-cell memory, suggesting galectin-1 could enhance flu vaccines and improve respiratory immunity against influenza infection. The post Key Immune Cells Identified That Could Strengthen Flu Vaccines appeared first on GEN - Genetic Engineering and Biotechnology News.
Overseen helpers in the lung tissue: After an influenza infection, certain immune cells derived from monocytes remain intact for months and support local memory T cells. In mice, their signal protein Galectin-1 also enhanced the immune response of an experimental nasal vaccine. The approach could open up new ways to improve protection directly in the airways, but is still preclinical. Rochester (U.S.A.). Flu vaccination can lead to severe diseas…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
